3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Gynecologic
5
Sarcoma
1
Plasma cell
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, T-Cell, Peripheral
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Waldenstrom Macroglobulinemia
1
Sarcoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Interventions
selinexor
1
pemigatinib
1
pembrolizumab
1
Trastuzumab
1
Gemcitabine
1
Fentanyl
1
Docetaxel
1
Cisplatin
1
Antineoplastic Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
selinexor
×
Myeloid
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available